| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_81e5e5b8bf9385af8644bb09b9c75df0 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2740-15043
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2830-008 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K48-0058
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N9-1205
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-86 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K48-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-54 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-86 |
| filingDate |
2007-04-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a3fe73f3d105d1fa9bb25d476061b5c1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d8fc1bb728483e82e0b05c8fbea932da
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_feb643af90da73d714c41297ba7240dd
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_aa57db4c058bbebb909cd4f62c482b0d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_072cf2ed0c772cfb9d393e50cdf1afb6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9e9431d335c5c806caa961dafd4abfab |
| publicationDate |
2009-09-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
ES-2325711-A1 |
| titleOfInvention |
EXPRESSION VECTORS UNDERSTANDING THE PROMOTER OF THE HUMAN PKLR GENE AND ITS USE FOR THE ELABORATION OF PHARMACEUTICAL COMPOSITIONS INTENDED FOR SOMATIC GENE THERAPY WITH SPECIFIC EXPRESSION IN ERYTHROID CELLS. |
| abstract |
Expression vectors comprising the promoternof the human PKLR gene and its use for the preparation of compositionsnPharmaceuticals for somatic gene therapy with expressionnspecific in erythroid cells. The present invention relatesnto the use of promoter regulatory sequences of the PKLR gene in thenproduction of vectors, with the exception of vectors that includenadeno-associated viruses, to be used in thenpreparation of pharmaceutical compositions intended for therapynsomatic gene in erythroid tissue. |
| priorityDate |
2007-04-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |